ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Geriatric Medicine

Top Geriatric Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAMELA MABEN MD

Geriatric Medicine

22,490

$1M

856
727 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

DAVID CARR MD

Geriatric Medicine

1,446

$122K

121
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $61

MARIA DELA ROSA MD

Geriatric Medicine

14,847

$786K

602
562 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $61

DEBRA BUCKLER DO

Geriatric Medicine

5,580

$270K

274
240 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

24%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $61

ASIF BHUTTO M.D.

Geriatric Medicine

3,303

$218K

179
153 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $61

STANLEY BIRGE MD

Geriatric Medicine

718

$37.1K

74
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

SEEMA IYER M.D.

Geriatric Medicine

5,618

$314K

458
341 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $61

JULIE GAMMACK MD

Geriatric Medicine

1,783

$115K

108
94 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

ERIC BARNES D.O.

Geriatric Medicine

68,611

$5.98M

1248
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$87
Average prescription price

Avg: $61

MARK GUNBY

Geriatric Medicine

17,649

$870K

810
730 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

WIT JAMRY MD

Geriatric Medicine

30,529

$2.43M

482
333 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $61

ABRAHAM BARAKE M.D.

Geriatric Medicine

7,023

$450K

442
411 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

CHANTRI TRINH MD

Geriatric Medicine

11,605

$510K

339
282 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $61

RAFI KEVORKIAN MD

Geriatric Medicine

15,047

$1.05M

402
242 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $61

CAROL MARTIN MD

Geriatric Medicine

2,258

$76.6K

394
350 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $61

EDWARD HEIDBRIER MD PC

Geriatric Medicine

4,095

$214K

288
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

MIRIAM RODIN MD

Geriatric Medicine

2,593

$128K

173
144 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

IQBAL AMIN M.D.

Geriatric Medicine

51,332

$2.79M

940
783 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

CHARLES CRECELIUS M.D.

Geriatric Medicine

16,844

$1.17M

557
530 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

KRISTI SHAUMEYER MD

Geriatric Medicine

9,404

$511K

331
262 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

25%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

RICHARD ONEILL M.D.

Geriatric Medicine

11,752

$690K

496
384 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

MARJON GILLBANKS M.D.

Geriatric Medicine

6,945

$363K

359
330 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

TONY TANG M. D.

Geriatric Medicine

12,107

$542K

281
238 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

KARMEL CAROTHERS M.D.

Geriatric Medicine

7,309

$362K

371
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $61

BRUCE LOWRIE MD

Geriatric Medicine

3,656

$260K

148
121 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank